Explore
Validate
Learn
Western blot
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [1]
- Comments [0]
- Validations
- Western blot [1]
- Other assay [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MA5-26672 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- PAFAH1B3 Monoclonal Antibody (OTI5D2)
- Antibody type
- Monoclonal
- Antigen
- Recombinant full-length protein
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- OTI5D2
- Vial size
- 100 µL
- Concentration
- 1 mg/mL
- Storage
- -20° C, Avoid Freeze/Thaw Cycles
Submitted references PAFAH1B3 predicts poor prognosis and promotes progression in lung adenocarcinoma.
Tang S, Ni J, Chen B, Sun F, Huang J, Ni S, Tang Z
BMC cancer 2022 May 9;22(1):525
BMC cancer 2022 May 9;22(1):525
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis of PAFAH1B3 in HEK293T cells in untransfected (Left lane) and transfected (Right lane) samples using 5 µg per lane. The samples were separated by SDS-PAGE and probed with PAFAH1B3 (Product # MA5-26672) monoclonal antibody.
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- High PAFAH1B3 expression in LUAD is associated with poor survival of LUAD patients. a Representative immunohistochemical staining pictures for PAFAH1B3 with different staining intensity in LUAD tissues. b Kaplan-Meier survive curve of differential PAFAH1B3 protein expression in 79 tumor tissues in LUAD tissue microarray. c Kaplan-Meier survive curve of different TNM stage in 79 tumor tissues in LUAD tissue microarray
